about
The Treatment of Cushing's Disease.Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesThe risks of overlooking the diagnosis of secreting pituitary adenomasCabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicityDoes somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 PatientsNewer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson's disease.Update on medical treatment for Cushing's disease.Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasiaGlobal clinical response in Cushing's syndrome patients treated with mifepristoneAdvances in understanding pituitary tumorsCarboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoformsClinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea.Cushing's syndrome: epidemiology and developments in disease management.Cushing's syndrome in childhood: update on genetics, treatment, and outcomes.Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary AdenomasAlgorithm development and the clinical and economic burden of Cushing's disease in a large US health plan databaseMultiplicity of hormone-secreting tumors: common themes about cause, expression, and management.Choroidal and Retinal Abnormalities by Optical Coherence Tomography in Endogenous Cushing's Syndrome.Recent advances in the medical treatment of Cushing's disease.A Case Report of Cushing's Disease Presenting as Hair Loss.Pasireotide: a review of its use in Cushing's disease.Efficacy of medical treatment in Cushing's disease: a systematic review.Managing Cushing's disease: the state of the art.Current status on histological classification in Cushing's disease.Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.Medical combination therapies in Cushing's disease.The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids.Currently used and investigational drugs for Cushing´s disease.Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy.Treatment patterns in Cushing's disease patients in two large United States nationwide databases: application of a novel, graphical methodology.A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.
P2860
Q27010590-35A44BE1-D750-4B0A-B052-F2ADD39E3A6BQ27021274-64C149C5-8B41-4A16-A7B4-D5F3676051D9Q28076013-A17D02D8-AFDC-4595-BADF-38A286BDDFB8Q28076665-E7C16A65-114F-4FEC-9200-C7A34E5B0F6EQ28539553-0B11DEC4-7CE4-4BD4-A1AB-C785C5A8CA0BQ33569023-A04139DC-FD00-430A-9D5A-26458849961DQ33569920-6E47CEA9-BE89-4CA2-8A87-0033635E902CQ33572858-59846BD2-EFD0-4070-8CA7-7464534F1CF3Q33802284-5ABA3729-090A-4CF3-8E8D-8DD68A6FD80FQ34431162-88431A24-9477-471A-A2DB-95D35D3C4162Q34629187-16FF1EC9-FC52-4A29-8CDE-2879230EEF71Q34660143-680B65C6-DFE3-4011-A4CE-06AF56C1A4B2Q35122812-C042A0CC-3DD7-47AE-9814-1BB62146A8F1Q35260959-A19398AA-E79F-4CCD-8F60-D19B614FD773Q35531889-17524399-D117-40BB-AC03-A1192896891DQ35555316-7BD48A20-306C-4BB0-8247-281DFCA66B64Q36231629-AC408EC6-2662-4F04-B3DE-AFA8C2AE03E8Q36704444-9DD9937D-411B-4DA0-B430-4990E12519A9Q37071229-560309AB-7B7C-41C0-8886-9AFE2A0A01D0Q37486699-CC9FF368-443E-4A2D-BDA0-EE46FA1D3450Q37621524-5E1B8784-B0B1-428C-B884-EE5F8681E3DCQ37695097-0F884DC3-8D63-4A98-A75A-B191C57F3294Q38100715-59556454-1A9D-4D46-A444-7D487AE848D1Q38151882-72E66788-760B-4C77-A243-879CA42A4E1EQ38177740-EA23BF83-DDD0-4C15-A1E7-179275274CB7Q38287030-25BE0DD7-0446-465A-BED9-435BE27767DBQ38307934-FCD0A687-D0E6-4290-BD35-0A0C057EA136Q38342520-BB5EBD76-F61F-4362-A4C3-FDC3904B83C0Q38982619-F09F69D5-EABF-413B-9F3B-8556581D4B39Q39022297-A2F7194E-2DD8-431B-8F06-4A7BDD53DA88Q41069104-E77EC4A2-65E9-4F76-AEE9-A750C93E271AQ42290533-806D7C2A-0F74-44C0-9A6A-B15BE3EE30A1Q43656346-B5C3A99E-EF29-46CF-8E0B-A3E4EC64E287Q48194404-EA9D9D30-2729-4B63-8470-26A26018BC28Q50186163-ECE043CD-80A6-427D-8E6F-2059E0EE4C82Q55249109-CE8C5061-9CD8-4DA9-8777-7AE0DBC1C9CA
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Medical treatment of Cushing's disease.
@en
type
label
Medical treatment of Cushing's disease.
@en
prefLabel
Medical treatment of Cushing's disease.
@en
P356
P1476
Medical treatment of Cushing's disease.
@en
P2093
Leo J Hofland
Richard A Feelders
P304
P356
10.1210/JC.2012-3126
P407
P577
2013-01-23T00:00:00Z